C16H19N3O3
Neat
301.35
313369-16-3; ethyl (10R, 15S)-3-oxo-1, 4, 12-triazatetracyclo[7.6.1.05, 16.010, 15]hexadeca-5, 7, 9(16)-triene-12-carboxylate; (6bR, 10aS)-Ethyl 2-oxo-2, 3, 6b, 7, 10, 10a-hexahydro-1H-pyrido[3', 4':4, 5]pyrrolo[1, 2, 3-de]quinoxaline-8(9H)-carboxylate; Lumateperone Impurity N3; Q3URB4V7JE; SCHEMBL3304883; SCHEMBL29456967; QXNQHNWWRRMQPS-AAEUAGOBSA-N; 1H-Pyrido[3', 4':4, 5]pyrrolo[1, 2, 3-de]quinoxaline-8(7H)-carboxylic acid, 2, 3, 6b, 9, 10, 10a-hexahydro-2-oxo-, ethyl ester, (6bR, 10aS)-; Lumateperone Impurity N6and enantiomer; 313544-32-0; (6bR, 10aS)-2-oxo-2, 3, 6b, 9, 10, 10a-hexahydro-1H, 7H-pyrido[3', 4':4, 5]pyrrolo[1, 2, 3-de]quinoxaline-8-carboxylic acid ethyl ester; (6bR, 10aS)-ethyl 2, 3, 6b, 9, 10, 10a-hexahydro-2-oxo-1H-pyrido[3', 4':4, 5]-pyrrolo[1, 2, 3-de]quinoxaline-8-carboxylate; ethyl (10R, 15S)-3-oxo-1, 4, 12-triazatetracyclo[7.6.1.0, .0, hexadeca-5, 7, 9(16)-triene-12-carboxylate; ethyl (10R, 15S)-3-oxo-1, 4, 12-triazatetracyclo[7.6.1.0516.01 degrees 15]hexadeca-5(16), 6, 8-triene-12-carboxylate; ethyl (6bR, 10aS)-2-oxo-2, 3, 6b, 9, 10, 10a-hexahydro-1H-pyrido[3', 4':4, 5]pyrrolo[1, 2, 3-de]quinoxaline-8(7H)-carboxylate; Ethyl (6bR, 10aS)-2, 3, 6b, 9, 10, 10a-hexahydro-2-oxo-1H-pyrido[3', 4':4, 5]pyrrolo[1, 2, 3-de]quinoxaline-8(7H)-carboxylate; ethyl (6bR, 10aS)-2-oxo-2, 3, 6b, 9, 10, 10a-hexahydro-1H-pyrido[3', 4':4, 5]pyrrolo[1, 2, 3-de]quinoxaline-8(7H)-carboxylate; ethyl-(6bR, 10aS)-2-oxo-2, 3, 6b, 9, 10, 10a-hexahydro-1H-pyrido[3', 4':4, 5]pyrrolo[1, 2 and 3-de]quinoxaline-8(7H)-carboxylate
ethyl (10R, 15S)-3-oxo-1, 4, 12-triazatetracyclo[7.6.1.05, 16.010, 15]hexadeca-5, 7 and 9(16)-triene-12-carboxylate
InChI=1S/C16H19N3O3/c1-2-22-16(21)18-7-6-13-11(8-18)10-4-3-5-12-15(10)19(13)9-14(20)17-12/h3-5,11,13H,2,6-9H2,1H3,(H,17,20)/t11-,13-/m0/s1